Tropical Journal of Pharmaceutical Research

Original Research Article | OPEN ACCESS

Erratum “Loureirin B attenuates amiodarone-induced pulmonary fibrosis by suppression of TGFβ1/Smad2/3 pathway”

Weixiu Ma¹, Haixia Shi², Guangming Wei³, Mao Hua¹, Jinhua Ma⁴, Jinxia Cui¹, Honggang Yu⁵

¹Department of Respiratory Medicine, Affiliated Hospital of Qinghai University; ²Department of Emergency Medical, Affiliated Hospital of Qinghai University, Xining City, Qinghai Province 810000; ³Department of Nuclear Medicine, The Second Affiliated Hospital of Air Force Military Medical University, Xi'an City, Shaanxi Province 710038; ⁴Department of Oncology, Affiliated Hospital of Qinghai University, Xining City, Qinghai Province 810000; ⁵Department of Pulmonary Disease, Xi’an Hospital of Traditional Chinese Medicine, Xi'an City, Shaanxi Province 710000, China.

For correspondence:- Honggang Yu Email: GHY76Ykju@163.com Tel:+862989626831

Accepted: 22 June 2020 Published: 30 November 2020

Citation: Ma W, Shi H, Wei G, Hua M, Ma J, Cui J, et al. Erratum “Loureirin B attenuates amiodarone-induced pulmonary fibrosis by suppression of TGFβ1/Smad2/3 pathway”. Trop J Pharm Res 2020; 19(11):2477-2477 doi: 10.4314/tjpr.v19i11.31

© 2020 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Erratum

Ma et al. Loureirin B attenuates amiodarone-induced pulmonary fibrosis by suppression of TGFβ1/Smad2/3 pathway. Trop J Pharm Res 2020; 19(7):1371-1376 doi: http://dx.doi.org/ 10.4314/tjpr.v19i7.5

Authors’ addresses: The correct addresses of the authors are the ones provided above.

Contribution of authors: Weixiu Ma and Haixia Shi contributed equally to the work.

Citation: Ma W, Shi H, Wei G, Hua M, Ma J, Cui J. Loureirin B attenuates amiodarone-induced pulmonary fibrosis by suppression of TGFβ1/Smad2/3 pathway. Trop J Pharm Res 2020; 19(7):1371-1376 doi: http://dx.doi.org/10.4314/tjpr.v19i7.5. Erratum: 2020; 19(11):2477 http://dx.doi.org/ 10.4314/tjpr.v19i11.31

Keywords: Amiodarone, Loureirin B, Pulmonary fibrosis, Smad, Inflammation